BRIEF-Zimmer Biomet announces FDA approval of knee osteoarthritis vaccine

* Zimmer Biomet announces FDA approval of expanded 26-week

efficacy claim for gel-one cross-linked hyaluronate for

treatment of pain associated with knee osteoarthritis

Source text for Eikon:...

Read more